Elemer Piros

Stock Analyst at LUCID CAPITAL MARKETS

(1.26)
# 2008
Out of 5,441 analysts
143
Total ratings
Success rate
Average return
49 Stocks
Name Action PT Current % Upside Ratings Updated
BTAI BioXcel Therapeutics
Reiterates: Buy
66 66
6.36 937.74% 2 Jul 15, 2025
FBLG FibroBiologics
Initiates Coverage On: Buy
12
0.55 2081.82% 1 Dec 12, 2024
THAR Tharimmune
Initiates Coverage On: Buy
17
1.17 1352.99% 1 Dec 6, 2024
QNCX Quince Therapeutics
Initiates Coverage On: Buy
11
1.58 596.2% 1 Oct 29, 2024
MNPR Monopar Therapeutics
Initiates Coverage On: Buy
50
31.34 59.54% 6 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
17
1.42 1097.18% 1 Sep 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
n/a n/a 1 Aug 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
107 107
2.25 4655.56% 1 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
14 14
0.85 1547.06% 1 Jul 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
67 67
2.82 2275.89% 1 Jul 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
43
3.06 1305.23% 1 Jun 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
6.09 195.57% 7 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 8
1.15 552.17% 3 Sep 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
15 15
3.96 278.79% 8 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
21
9.98 110.42% 8 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
38
4.33 777.6% 9 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
40
0.68 5782.35% 2 Jul 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
50
4.01 1146.88% 5 Jun 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
114
7.28 1465.93% 3 Jun 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
260 200
3.79 5177.04% 6 Jun 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
23
3.41 574.49% 2 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
33
11.78 180.14% 3 Mar 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11
1.12 882.14% 2 Feb 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
40
23.87 67.57% 7 Apr 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
40
n/a n/a 3 Jan 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
37
1.43 2487.41% 1 Dec 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
38 32
4.6 595.65% 2 Jun 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
128 124
n/a n/a 7 May 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
n/a n/a 1 Apr 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
77
11.39 576.03% 2 Dec 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
70
1.86 3663.44% 1 Oct 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
240
n/a n/a 1 Sep 17, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 5 Sep 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
21 24
1.3 1746.15% 4 May 28, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
225 75
n/a n/a 2 May 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
24 50
17.2 190.7% 5 Nov 19, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
33
5.24 529.77% 2 Oct 22, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
191 186
19 878.95% 4 Aug 8, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
n/a
n/a n/a 3 Jul 11, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
26
4.13 529.54% 3 May 6, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
80 115
n/a n/a 3 Feb 25, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
21
n/a n/a 1 Nov 7, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
28
137.58 -79.65% 1 Sep 11, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
14 17
2 750% 2 Aug 9, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
70 65
11.1 485.59% 2 Jun 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
525 850
6.28 13435.03% 1 Oct 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
204 84
n/a n/a 2 Sep 22, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
29
n/a n/a 1 Jul 20, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
35 21
12.56 67.2% 2 Jul 12, 2017